Never miss out on the latest news!
Over 4,000 healthcare professionals have already signed up.
This website is intended to provide information to an international audience outside the USA and UK
This section examines thromboprophylaxis of VTE, including guideline recommendations and the benefits and risks of anticoagulant therapy, and other treatment options
Routine preventive anticoagulant therapy – thromboprophylaxis – is an established standard of care for the prevention of VTE in patients who have had major orthopaedic surgery.1
Despite the well-recognized risks of VTE, use of appropriate prophylaxis remains low. A multinational, cross-sectional audit including 32 countries – the ENDORSE (Epidemiologic International Day for the Evaluation of Patients at Risk for Venous Thromboembolism in the Acute Hospital Care Setting) survey – showed that:3,4
Proportions of patients (A) at risk of VTE and (B) receiving recommended prophylaxis.
Data from the ENDORSE survey3